Interleukin-12 (IL-12) and
IL-23 share a common chain. Yet, their production in response to pathogens is differentially regulated, and their functions are distinct and often antithetic.
IL-12 is involved in the induction or amplification of the T-helper (Th) type 1 response, whereas
IL-23 has been associated with the generation of the Th17 response and
IL-17 production. Mycobacterium tuberculosis and yeast
zymosan induce
IL-23, but in the absence of other stimuli, no
IL-12 is induced in human dendritic cells (DCs). The stimulation of
IL-23 by M.
tuberculosis was mostly explained by the triggering of
Toll-like receptor (TLR2) and the
cytoplasmic receptor nucleotide oligomerization domain (NOD)-containing
protein 2, whereas
zymosan induces
IL-23 primarily by stimulating the
beta-glucan receptor dectin-1 alone or in combination with TLR2.
IL-23,
IL-6,
transforming growth factor (TGF-beta1), and IL-1beta in supernatants from activated human DCs induce human naive CD4(+) T cells to produce
IL-17. These data are consistent with various recent reports that
TGF-beta is an inducer of
IL-17 production both in human and in mouse cells. However,
IL-1 is necessary in combination with some or all of the other
cytokines to induce
IL-17 production in human T cells. The ability of various stimuli to induce Th17 cells depends not only on their induction of
IL-23,
IL-6, and
TGF-beta production in DCs but also on their ability to activate directly or indirectly the
inflammasome and to induce IL-1beta.